Published online
doi:10.1083/jcb.200710215
The Journal of Cell Biology, Vol. 181, No. 2, 293-307
The Rockefeller University Press, 0021-9525 $30.00
© Ramírez-Valle et al.
eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy
Francisco Ramírez-Valle1,
Steve Braunstein1,
Jiri Zavadil2,
Silvia C. Formenti3, and
Robert J. Schneider1
1 Department of Microbiology, 2 Department of Pathology, and 3 Department of Radiation Oncology, New York University School of Medicine, New York, NY 10016
Correspondence to Robert J. Schneider: schner01{at}med.nyu.edu
Translation initiation factors have complex functions in cells that are not yet understood. We show that depletion of initiation factor eIF4GI only modestly reduces overall protein synthesis in cells, but phenocopies nutrient starvation or inhibition of protein kinase mTOR, a key nutrient sensor. eIF4GI depletion impairs cell proliferation, bioenergetics, and mitochondrial activity, thereby promoting autophagy. Translation of mRNAs involved in cell growth, proliferation, and bioenergetics were selectively inhibited by reduction of eIF4GI, as was the mRNA encoding Skp2 that inhibits p27, whereas catabolic pathway factors were increased. Depletion or overexpression of other eIF4G family members did not recapitulate these results. The majority of mRNAs that were translationally impaired with eIF4GI depletion were excluded from polyribosomes due to the presence of multiple upstream open reading frames and low mRNA abundance. These results suggest that the high levels of eIF4GI observed in many breast cancers might act to specifically increase proliferation, prevent autophagy, and release tumor cells from control by nutrient sensing.
Abbreviations used in this paper: 4E-BP1, eIF4E binding protein 1; IRES, internal ribosome entry site; MDC, monodansylcadaverine; mTOR, mammalian target of rapamycin; uORF, upstream ORF.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
Related In this Issue article
-
An eIF for proliferation
- Nicole LeBrasseur
J. Cell Biol. 2008 181: 175.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., James, D., Howard, Z., Dudley, P., Hughes, G., Smith, L., Maguire, S., Hummersone, M., Malagu, K., Menear, K., Jenkins, R., Jacobsen, M., Smith, G. C.M., Guichard, S., Pass, M.
(2010). AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity. Cancer Res.
70: 288-298
[Abstract]
[Full Text]
-
Parsyan, A., Shahbazian, D., Martineau, Y., Petroulakis, E., Alain, T., Larsson, O., Mathonnet, G., Tettweiler, G., Hellen, C. U., Pestova, T. V., Svitkin, Y. V., Sonenberg, N.
(2009). The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis. Proc. Natl. Acad. Sci. USA
106: 22217-22222
[Abstract]
[Full Text]
-
Meric-Bernstam, F., Gonzalez-Angulo, A. M.
(2009). Targeting the mTOR Signaling Network for Cancer Therapy. JCO
27: 2278-2287
[Abstract]
[Full Text]
-
Muggia, F. M., Peters, G. J., Landolph, J. R. Jr.
(2009). XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on September 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center. Molecular Cancer Therapeutics
8: 992-999
[Abstract]
[Full Text]
-
LeBrasseur, N.
(2008). An eIF for proliferation. JCB
181: 175-175
[Full Text]